HealthyNCT04599322
Stabilometry Changes After Dry Needling in Flexor Digitoum Brevis
A study testing Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle in people with Healthy and Foot, run by Mayuben Private Clinic at 1 site in Spain.
Trial summary
The aim of this clinical trial is to check the balance effects of dry needling in the Flexor digitorum Brevis Read more about this study
- Who is it for?
- Ages 18 to 40 years
- Conditions the study is for
- Healthy, Foot, Dry Needling
- What is being tested?
- Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteSpain
- Study dates
- 9 Nov 2020to 16 Nov 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Healthy individuals
- Must have latent trigger point in Flexor Brevis Digitorum muscles
Who cannot join
- Previous lower extremities surgery.
- History of lower extremities injury with residual symptoms (pain, "giving-away" sensations) within the last year.
- Leg-length discrepancy more than 1 cm
- Balance deficits (determined by oral questionnaire regarding falls)
Trial locations and contacts
1 site in 1 country.
About this study
The aim of this clinical trial is to check the balance effects of dry needling in the Flexor digitorum Brevis
Read the detailed description
Eighteen healthy subjects wil be recruited for a quasi-experimental study. Participants will be from 18 to 40 years old, not obese. Participants will be measured before and after bilateral dry neddling in Flexor digitorum Brevis. The investigators will measure stabilometry variables with eyes open and closed.
Measures. Stabilometry will be measured by displacement of the center of pressures in X and Y with eyes open and closed , center of pressure (COP) with eyes open and closed, COP area with eyes open and closed, COP antero-posterior (a-p) and medio-lateral (m-lat) directions with eyes open and closed, and COP speed. Two trials will be recorded for each condition and the order of the conditions will be randomized across subjects, eyes open and eyes closed.
- Conditions
- Healthy, Foot, Dry Needling
- Being tested
- Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle
- Keywords
- Stabilometry, Dry needling, Trigger point
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis MuscleOther
Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle
| Study group | Role | What they receive |
|---|---|---|
| Bilateral dry needling in Flexor Brevis Digitorum in subjects with latent trigger point | Experimental | Bilateral dry needling in Flexor Brevis Digitorum in subjects with latent trigger point Receives: Other: Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stabilometry variable x displacement open eyes before dry needling
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with open eyes.
Measured: Through study completion, an average of 1 week
Stabilometry variable y displacement open eyes before dry needling
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with open eyes.
Measured: Through study completion, an average of 1 week
Stabilometry variable center of pressure area open eyes before dry needling
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes open.
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction open eyes before dry needling
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction open eyes before dry needling
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Stabilometry variable x displacement before dry needling with closed eyes
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with eyes closed.
Measured: Through study completion, an average of 1 month
Stabilometry variable y displacement before dry needling with closed eyes
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with closed eyes.
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure area before dry needling with closed eyes
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes closed.
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction before dry needling with closed eyes
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction before dry needling with closed eyes
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Secondary outcomes (10)
Stabilometry variable x displacement open eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with open eyes.
Measured: Through study completion, an average of 1 month
Stabilometry variable y displacement open eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with open eyes.
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure area open eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes open.
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with open eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with open eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Stabilometry variable x displacement with closed eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with eyes closed.
Measured: Through study completion, an average of 1 month
Stabilometry variable y displacement with closed eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with closed eyes.
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure area with closed eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes closed.
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with closed eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with closed eyes after intervention
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second).
Measured: Through study completion, an average of 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Oct 2020
- Study start9 Nov 2020
- Primary completion9 Nov 2020
- Study completion16 Nov 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Pretest posttest of bilateral Flexor digitorum Brevis dry needling intervention
- Masking
- None (open label)
- Enrolment
- 18 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mayuben Private Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, EVA MARIA MARTÍNEZ JIMENEZ, Mayuben Private Clinic
- Investigators
- Eva María Martínez-Jimenez, Principal investigator, Mayuben Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04599322
- Sponsor's protocol ID
- 2706201911419 B
- Status last verified
- Nov 2020
- First submitted
- 3 Oct 2020
- Last updated
- 18 Nov 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Salvioli S, Guidi M, Marcotulli G. The effectiveness of conservative, non-pharmacological treatment, of plantar heel pain: A systematic review with meta-analysis. Foot (Edinb). 2017 Dec;33:57-67. doi: 10.1016/j.foot.2017.05.004. Epub 2017 Jun 15.
PubMed 29126045David JA, Sankarapandian V, Christopher PR, Chatterjee A, Macaden AS. Injected corticosteroids for treating plantar heel pain in adults. Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009348. doi: 10.1002/14651858.CD009348.pub2.
PubMed 28602048Salom-Moreno J, Sanchez-Mila Z, Ortega-Santiago R, Palacios-Cena M, Truyol-Dominguez S, Fernandez-de-las-Penas C. Changes in spasticity, widespread pressure pain sensitivity, and baropodometry after the application of dry needling in patients who have had a stroke: a randomized controlled trial. J Manipulative Physiol Ther. 2014 Oct;37(8):569-79. doi: 10.1016/j.jmpt.2014.06.003. Epub 2014 Sep 8.
PubMed 25199825Cotchett MP, Munteanu SE, Landorf KB. Effectiveness of trigger point dry needling for plantar heel pain: a randomized controlled trial. Phys Ther. 2014 Aug;94(8):1083-94. doi: 10.2522/ptj.20130255. Epub 2014 Apr 3.
PubMed 24700136McNally EG, Shetty S. Plantar fascia: imaging diagnosis and guided treatment. Semin Musculoskelet Radiol. 2010 Sep;14(3):334-43. doi: 10.1055/s-0030-1254522. Epub 2010 Jun 10.
PubMed 20539958
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Stabilometry Changes After Dry Needling in Flexor Digitoum Brevis
- ClinicalTrials.gov ID
- NCT04599322
- Acronym / sponsor ID
- 2706201911419 B
- Conditions
- Healthy, Foot, Dry Needling
- Keywords
- Stabilometry, Dry needling, Trigger point
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 18 participants (actual)
- Lead sponsor
- Mayuben Private ClinicUniversity, hospital or other
- Study start
- 9 Nov 2020 (actual)
- Primary completion
- 9 Nov 2020 (actual)
- Study completion
- 16 Nov 2020 (actual)
- First posted
- 22 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this clinical trial is to check the balance effects of dry needling in the Flexor digitorum Brevis
Detailed description
Eighteen healthy subjects wil be recruited for a quasi-experimental study. Participants will be from 18 to 40 years old, not obese. Participants will be measured before and after bilateral dry neddling in Flexor digitorum Brevis. The investigators will measure stabilometry variables with eyes open and closed.
Measures. Stabilometry will be measured by displacement of the center of pressures in X and Y with eyes open and closed , center of pressure (COP) with eyes open and closed, COP area with eyes open and closed, COP antero-posterior (a-p) and medio-lateral (m-lat) directions with eyes open and closed, and COP speed. Two trials will be recorded for each condition and the order of the conditions will be randomized across subjects, eyes open and eyes closed.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Pretest posttest of bilateral Flexor digitorum Brevis dry needling intervention
| Arm | Type | Receives |
|---|---|---|
| Bilateral dry needling in Flexor Brevis Digitorum in subjects with latent trigger point | Experimental | Other: Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis MuscleBilateral dry needling in Flexor Brevis Digitorum in subjects with latent trigger point |
Who may qualify
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Healthy individuals
- Must have latent trigger point in Flexor Brevis Digitorum muscles
Key exclusion criteria (4 listed)
- Previous lower extremities surgery.
- History of lower extremities injury with residual symptoms (pain, "giving-away" sensations) within the last year.
- Leg-length discrepancy more than 1 cm
- Balance deficits (determined by oral questionnaire regarding falls)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis MuscleBilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle | Other | Bilateral dry needling in Flexor Brevis Digitorum in subjects with latent trigger point |
Primary outcome
Stabilometry variable x displacement open eyes before dry needling
Time frame: Through study completion, an average of 1 week
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with open eyes.
Stabilometry variable y displacement open eyes before dry needling
Time frame: Through study completion, an average of 1 week
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with open eyes.
Stabilometry variable center of pressure area open eyes before dry needling
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes open.
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction open eyes before dry needling
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second).
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction open eyes before dry needling
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second).
Stabilometry variable x displacement before dry needling with closed eyes
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in X (in milimeters) with eyes closed.
Stabilometry variable y displacement before dry needling with closed eyes
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of pressures in Y (in milimeters) with closed eyes.
Stabilometry variable center of pressure area before dry needling with closed eyes
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure displacement of the center of Pressure (COP) area (in milimeters²) with eyes closed.
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction before dry needling with closed eyes
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the anteroposterior(a-p) direction (in milimeters/second).
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction before dry needling with closed eyes
Time frame: Through study completion, an average of 1 month
Stabilometry assessment was used and subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline. Stabilometry variables measure center of pressure speed displacement of the latero-lateral(lat-lat) direction (in milimeters/second).
10 secondary outcomes
Stabilometry variable x displacement open eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable y displacement open eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable center of pressure area open eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with open eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with open eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable x displacement with closed eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable y displacement with closed eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable center of pressure area with closed eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the anteroposterior(a-p) direction with closed eyes after intervention
Time frame: Through study completion, an average of 1 month
Stabilometry variable center of pressure speed displacement of the latero-lateral(lat-lat) direction with closed eyes after intervention
Time frame: Through study completion, an average of 1 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2020.
- Background: PubMed 29126045Salvioli S, Guidi M, Marcotulli G. The effectiveness of conservative, non-pharmacological treatment, of plantar heel pain: A systematic review with meta-analysis. Foot (Edinb). 2017 Dec;33:57-67. doi: 10.1016/j.foot.2017.05.004. Epub 2017 Jun 15.
- Background: PubMed 28602048David JA, Sankarapandian V, Christopher PR, Chatterjee A, Macaden AS. Injected corticosteroids for treating plantar heel pain in adults. Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009348. doi: 10.1002/14651858.CD009348.pub2.
- Background: PubMed 25199825Salom-Moreno J, Sanchez-Mila Z, Ortega-Santiago R, Palacios-Cena M, Truyol-Dominguez S, Fernandez-de-las-Penas C. Changes in spasticity, widespread pressure pain sensitivity, and baropodometry after the application of dry needling in patients who have had a stroke: a randomized controlled trial. J Manipulative Physiol Ther. 2014 Oct;37(8):569-79. doi: 10.1016/j.jmpt.2014.06.003. Epub 2014 Sep 8.
- Background: PubMed 24700136Cotchett MP, Munteanu SE, Landorf KB. Effectiveness of trigger point dry needling for plantar heel pain: a randomized controlled trial. Phys Ther. 2014 Aug;94(8):1083-94. doi: 10.2522/ptj.20130255. Epub 2014 Apr 3.
- Background: PubMed 20539958McNally EG, Shetty S. Plantar fascia: imaging diagnosis and guided treatment. Semin Musculoskelet Radiol. 2010 Sep;14(3):334-43. doi: 10.1055/s-0030-1254522. Epub 2010 Jun 10.
- Individual participant dataSharing planned: No
Related trials for Healthy
Not yet recruitingPhase 1
A Study of Phenytoin Mucoadhesive Film for Oral Ulcers in Healthy Volunteers
Oral Ulcer, Oral Mucositis
Not yet recruiting
SUVY VerSus SAccharose (SUVISA)
Healthy Volunteers, Erythritol
RecruitingPhase 1
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children
Seasonal Influenza
Not yet recruitingObservational study
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene
PIEZO2-Deficiency Syndrome
Enrolling by invitationObservational study
Connors Protocol for the Management and Use of Stored Human Specimens (Stored Human Specimens)
Healthy Volunteer Samples
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eva María Martínez-Jimenez principal investigator
Mayuben Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Bilateral dry needling in latent trigger points of the Flexor digitorum Brevis Muscle in people with Healthy and Foot, run by Mayuben Private Clinic at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stabilometry variable x displacement open eyes before dry needling (time frame: Through study completion, an average of 1 week). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04599322, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2020.